Ipsen H1 FY26 core operating income climbs 28.8% to €844.9 million; sales rise 20.4% to €2.19 billion
Reuters2026/07/30 05:05- Ipsen posted H1 2026 total sales of €2.19 billion, up 20.4% from a year earlier.
- Core operating income climbed 28.8% to €844.9 million, lifting the core operating margin by 2.5 percentage points to 38.6%.
- IFRS operating income rose 25.1% to €564.8 million, while IFRS net profit increased 20% to €402.6 million.
- CEO David Loew cited broad-based momentum across all three therapeutic areas, with the portfolio beyond Somatuline accelerating.
- Upgraded FY 2026 outlook: total sales growth above 20% at constant currency, core operating margin above 37% of total sales.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Storage Giant Offers Huge Bonuses Again: Micron Awards Up to 68 Months’ Bonus
Micron Technology has announced record-breaking bonuses for its employees in Taiwan, ranging from 35 to 68 months’ salary, with a minimum cash compensation of 1.7 million New Taiwan dollars. However, the Taoyuan union, representing about two-thirds of Micron’s workers in Taiwan, has refused to accept the offer, insisting that 15% of operating profits be included in the bonus distribution and maintaining the threat of a strike.
Dogecoin ETF Closure Sets October Exit for Bitwise BWOW Holders
Crypto prices
More
